Ocular Therapeutix

Driven by a vision

Pioneering a new era of drug delivery in ophthalmology

Ocular Therapeutix is a biopharmaceutical company aspiring to be a leader in ophthalmology by leveraging its proprietary hydrogel technology to develop transformational drug products that enhance the patient and provider experience.

Featured Press Release

FDA Accepts DEXTENZA NDA

PDUFA Date: Dec. 28, 2018